Drug Development

Jun 01, 2018
By Pharmaceutical Technology Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
Jun 01, 2018
By Pharmaceutical Technology Editors
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
Jun 01, 2018
By Pharmaceutical Technology Editors
Lonza has added four liver cell types to its hepatocytes portfolio for testing of in vitro drug models.
May 30, 2018
By Pharmaceutical Technology Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 30, 2018
By Pharmaceutical Technology Editors
The new draft guidance addresses the premarketing assessment of a drug’s effect on blood pressure.
May 23, 2018
By Pharmaceutical Technology Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 23, 2018
By Pharmaceutical Technology Editors
Allergan will buy a potential depression treatment from Aptinyx.
May 23, 2018
The combination of translatable in-vitro and in-vivo assays, coupled with expertise in immunology and oncology helps facilitate the progression of novel oncology therapeutics from hit identification to investigational new drug submission.
May 17, 2018
By Pharmaceutical Technology Editors
The FDA commissioner released a statement expressing the agency’s plan to address tactics used by pharma companies to delay generic-drug competition.
May 16, 2018
By Pharmaceutical Technology Editors
ExcipientFest has been acquired by IPEC and rebranded as Excipient World.
native1_300x100
lorem ipsum